LungLife AI

LungLife AI is a clinical diagnostics company that focuses on the early detection and management of lung cancer through artificial intelligence (AI) and molecular analysis of biomarkers in blood. The company's flagship product is the LungLB® test, a blood-based assay designed to provide clinicians with additional information when evaluating indeterminate lung nodules. This test helps in the early diagnosis of lung cancer, aiming to improve patient outcomes by facilitating timely interventions.